BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND DDX3X, DDX14, 1654, ENSG00000215301, DBX, DDX3, HLP2 AND Prognosis
4 results:

  • 1. Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia.
    Abla O; Ries RE; Triche T; Gerbing RB; Hirsch B; Raimondi S; Cooper T; Farrar JE; Buteyn N; Harmon LM; Wen H; Deshpande AJ; Kolb EA; Gamis AS; Aplenc R; Alonzo T; Meshinchi S
    Blood Adv; 2024 Apr; 8(8):2005-2017. PubMed ID: 38306602
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Label-free discrimination of tumorigenesis stages using in vitro prostate cancer bone metastasis model by Raman imaging.
    Kar S; Jaswandkar SV; Katti KS; Kang JW; So PTC; Paulmurugan R; Liepmann D; Venkatesan R; Katti DR
    Sci Rep; 2022 May; 12(1):8050. PubMed ID: 35577856
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMT.
    Battipaglia G; Boumendil A; Labopin M; Ciceri F; Tischer J; Stelljes M; Ehninger G; Beelen D; Finke J; Van Lint MT; Eder M; Afanasyev B; Fanin R; Mohty M; Ruggeri A; Nagler A
    Bone Marrow Transplant; 2019 Sep; 54(9):1499-1510. PubMed ID: 30718798
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Results of RS-99 protocol for childhood solid tumors.
    Cai JY; Tang JY; Pan C; Xu M; Xue HL; Zhou M; Dong L; Ye QD; Jiang H; Shen SH; Chen J
    World J Pediatr; 2010 Feb; 6(1):43-9. PubMed ID: 20143210
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.